The GLP-1 revolution arrives at Europe’s doorstep: are we ready? a call to action for romanian pharmacotherapy

March 26, 2026

Dragoș Crețoiu 1, 2 *

1 Department of Medical Genetics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2 Polizu Clinical Hospital, Alessandrescu-Rusescu National Institute of Mother and Child Health, Bucharest, Romania
* Correspondence to: Dragoș Crețoiu, Department of Medical Genetics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. E-mail: dragos@cretoiu.ro

Previous Story

Incretin-based therapy for obesity, part 1: effects on weight loss and body composition

Next Story

Difficulties in the management of a patient with heart failure and atrial arrhythmia